open
serve
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
News
Discover
Civics
Toggle civics trackers
Markets
open
serve
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
Apps
IJR News — today's news from every side
Ask Genius
Apps
Ask Genius
x/united-states-food-and-drug-administration
— Jul 23, 2026
GSK earns FDA approval for Jideytro
GSK won FDA approval for Jideytro (zidesamtinib), its ROS1 inhibitor for ROS1-positive non-small cell lung cancer, ahead of the September 18 deadline as part of its Nuvalent acquisition. The treatment, showing a 44% response rate in trials, positions GSK to compete in lung cancer and supports ongoing development of additional Nuvalent assets like neladalkib and ris-rez.
9 sources · Jul 23, 2026